Sirius NeoSight
Cancer detection technology development
- B2B
About Sirius NeoSight
Sirius NeoSight is an innovative company specializing in detecting early-stage cancers, relapses, and monitoring therapeutic effectiveness using patented cutting-edge technology
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Lyon, Auvergne-Rhône-Alpes, France
- Founded
- 2023
- Revenue
- $4.9M – $38.7MTamtam estimate
- Website
- sirius-neosight.com
Sirius NeoSight at a glance
Sirius NeoSight is a B2B company in the Biotechnology Research industry, headquartered in Lyon, Auvergne-Rhône-Alpes, France.
Sirius NeoSight was founded in 2023.
Sirius NeoSight has 11–50 employees.
Sirius NeoSight's revenue is $4.9M – $38.7M (Tamtam estimate).
Selling to companies like Sirius NeoSight?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies